Ligand Pharmaceuticals Incorporated (LGNXZ)

OTCMKTS · Delayed Price · Currency is USD
0.0015
0.00 (0.00%)
At close: Aug 29, 2025
Market Cap3.27B
Revenue (ttm)187.58M
Net Income (ttm)-75.86M
Shares Outn/a
EPS (ttm)-4.00
PE Ration/a
Forward PE23.52
Dividendn/a
Ex-Dividend Daten/a
Volume175,000
Average Volume69,790
Open0.0020
Previous Closen/a
Day's Range0.0015 - 0.0020
52-Week Range0.0010 - 0.0050
Beta0.71
RSI42.20
Earnings DateNov 7, 2025

About Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neurobla... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1987
Employees 68
Stock Exchange OTCMKTS
Ticker Symbol LGNXZ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.